Leptin, Obestatin and Apelin levels in patients with obstructive sleep apnoea syndrome

Medical Science Monitor

Volumn 17, Issue 3, 2011, Pages 10-

  Zirlik, Sabine ^a   Hauck, Tabea ^a   Fuchs, Florian Siegfried ^a   Neurath, Markus Friedrich ^a   Konturek, Peter Christopher ^b   Harsch, Igor Alexander ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Thuringia Clinic   (Germany)

Author keywords

Adipose tissue hormones; Apelin; CPAP therapy; Leptin; Obestatin; OSAS

Indexed keywords

APELIN; LEPTIN; OBESTATIN;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; HOMA INDEX; HORMONE BLOOD LEVEL; HUMAN; MALE; METABOLIC PARAMETERS; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME; TREATMENT OUTCOME;

EID: 79952399452     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.881450     Document Type: Article

References (38)

1. http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/
2. Chin K, Shimizu K, Nakamura T et al: Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation, 1999; 100(7): 706-12
3. Harsch IA, Konturek PC, Koebnick C et al: Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J, 2003; 22(2): 251-57
4. Tatemoto K, Hosoya M, Habata Y et al: Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun, 1998; 251(2): 471-76
5. Lee DK, Cheng R, Nguyen T et al: Characterization of apelin, the ligand for the APJ receptor. J Neurochem, 2000; 74(1): 34-41
6. Cox CM, DÁgostino S, Miller MK et al: Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol, 2006; 296(1): 177-89
7. O'Carroll AM, Selby T, Palkovits M, Lolait SJ: Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta, 2000; 1492(1): 72-80
8. Eyries M, Siegfried G, Ciumas M et al: Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res, 2008; 103(4): 432-40
9. Harsch IA, Hahn EG, Konturek PC: Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. Med Sci Monit, 2005; 11(3): RA70-75
10. Glassford AJ, Yue P, Sheikh AY et al: HIF-1 regulates hypoxia- and insulin- induced expression of apelin in adipocytes. Am J Physiol Endocrinol Metab, 2007; 293(6): E1590-96
11. Tang SQ, Jiang Q, Zhang YL et al: Obestatin: its physicochemical characteristics and physiological functions. Peptides, 2008; 29(4): 639-45
12. Bodosi B, Gardi J, Hajdu I et al: Rhythms of ghrelin, leptin, and sleep in rats: effects of the normal diurnal cycle, restricted feeding, and sleep deprivation. Am J Physiol Regul Integr Comp Physiol, 2004; 287(5): R1071-79
13. Szentirmai E, Krueger J: Obestatin alters sleep in rats. Neurosci Lett, 2006; 404(1-2): 222-26
14. Ip MS, Lam K, Ho C et al: Serum leptin and vascular risk factors in obstructive sleep apnea. Chest, 2000; 118(3): 580-86
15. Boden G, Chen X, Kolaczynski JW, Polansky M: Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest, 1997; 100(5): 1107-13
16. Vgontzas AN, Papanicolaou D, Bixler EO et al: Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab, 2000; 85(3): 1151-58
17. American Thoracic Society: Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March 1944. Am J Respir Crit Care Med, 1994; 150(6 Pt 1): 1738-45
18. Penzel T, Hajak G, Hoffmann RM: Empfehlungen zur Dürchführung und Auswertung polygraphischer Ableitungen im diagnostischen Schlaflabor. EEG-EMG, 1993; 24: 65-70 [in German]
19. Ficker JH, Wiest G, Lehnert G et al: Evaluation of an auto-CPAP device for treatment of obstructive sleep apnoea. Thorax, 1998; 53(8): 643-48
20. Rechtschaffen A, Kahles A: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Public Health Service, US Government Printing Office, 1968
21. Bonnet M, Charley D, Carskadon MA: EEG arousals: Scoring rules and examples. Sleep, 1992; 15: 174-84
22. Hernandez C, Abreu J, Abreu P et al: Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP. Eur Respir J, 2007; 30: 496-500
23. Tokuda F, Sando Y, Matsui H et al: Serum Levels of Adipocytokines, Adiponectin and Leptin, in Patients with Obstructive Sleep Apnea Syndrome. Inter Med, 2008; 47: 1843-49
24. Shapiro GK, Shapiro GM: Factors that influence CPAP adherence: an overview. Sleep Breath, 2010; 14(4): 323-35
25. Henley DE, Buchanan F, Gibson R et al: Plasma apelin levels in obstructive sleep apnea and the effect of continuous positive airway pressure therapy. J Endocrinol, 2009; 203: 181-88
26. Ciftci TU, Kokturk O, Bukan N, Bilgihan A: Leptin and Ghrelin Levels in Patients with Obstructive Sleep Apnea Syndrome. Respiration, 2005; 72: 395-401
27. Aleman MR, Santolaria F, Batista N et al: Leptin role in advanced lung cancer. A mediator of the acute phase response or marker of the status of nutrition? Cytokine, 2002; 19: 21-26
28. J: Apelin and visfatin: Unique "beneficial"adipokines upregulated in obesity? Med Sci Monit, 2006; 12(6): RA112-19
29. Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira A: The Apelinergic System: The Role Played in Human Physiology and Pathology and Potential Therapeutic Applications. Arq Bras Cardiol, 2008; 90(5): 343-49
30. Boucher J, Masri B, Daviaud D et al: Apelin, a Newly Identified Adipokine Up-Regulated by Insulin and Obesity. Endocrinology, 2005; 146: 1764-71
31. Castan-Laurell I, Vitkova M, Daviaud D et al: Effect of hypocaloric dietinduced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. European Journal of Endocrinology, 2008; 158: 905-10
32. Rayalam S, Della-Fera MA, Krieg PA et al: A putative role for apelin in the etiology of obesity. Biochem Biophys Res Commun, 2008; 368: 815-19
33. Cox CM, D'Agostino SL, Miller MK et al: Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular developement of the frog embryo. Dev Biol, 2006; 296: 177-89
34. Reimer MK, Pacini G, Ahrén B: Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology, 2003; 144(3): 916-21
35. Anderwald-Stadler M, Krebs M, Promintzer M et al: Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab, 2007; 293(5): E1393-98
36. Harsch IA, Pour Schahin S, Radespiel-Tröger M et al: Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med, 2004; 169: 156-62
37. Ip MS, Lam B, Ng MMT et al: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med, 2002; 165: 670-76
38. Harsch IA, Koebnick C, Wallaschofski H et al: Resistin levels in patients with obstructive sleep apnoea syndrome - the link to subclinical inflammation?. Med Sci Monit, 2004; 10(9): CR510-15